- Published at
- by marketscreener.com
mixed
mixed
Teijin, J-TEC, Mitsui Fudosan Co., Ltd. and National Cancer Center to Establish Regenerative Medicine Platform[Teijin,Japan Tissue Engineering] (PDF: 432.2 KB)
NEWS RELEASE
Teijin, J-TEC, Mitsui Fudosan and NCC to Establish
Regenerative Medicine Platform
Tokyo, Japan, September... | September 27, 2022